This document discusses bibliometrics, which is the quantitative analysis of academic publications and their impact. It defines bibliometrics and explains that bibliometric measures are used to evaluate the impact and spread of research information. Common impact measures discussed include the journal impact factor, which measures the average number of citations to papers in a journal, and the H-index, which measures both the productivity and impact of a researcher's body of work. The document also outlines bibliometric services and databases that can be used to perform bibliometric analysis, such as Web of Knowledge, Journal Citation Reports, and Scopus.
The document discusses the key elements and requirements for complying with the NIH Public Access Policy, which requires investigators funded by NIH to submit final peer-reviewed manuscripts to PubMed Central upon acceptance for publication. The three main elements are: 1) retaining author rights to submit to PMC, 2) submitting the manuscript to PMC or NIH's manuscript submission system, and 3) providing proof of compliance on grant applications. The PI is ultimately responsible for approving manuscript submissions, though an author other than the PI may submit.
The document summarizes the NIH Public Access Policy, which requires researchers receiving NIH funding to submit final peer-reviewed manuscripts to PubMed Central within 12 months of official publication. It outlines the three steps for compliance: 1) managing copyright by checking agreements and modifying if needed, 2) submitting manuscripts to the NIH system if required, and 3) including the PMCID in future NIH proposals. Benefits of complying include increased exposure and citation of work. Publishers have varying levels of support for submitting manuscripts.
COVID-19 and Changing Paradigm in Scholarly communication Vasantha Raju N
The document discusses how the COVID-19 pandemic has impacted scholarly communications. It notes that researchers are publishing preprints to disseminate their research on COVID-19 quickly. This has led traditional publishers to speed up peer review and make more literature open access. It also discusses how preprint servers are benefiting research by allowing quick sharing of findings and how preprints differ from traditional publications. Finally, it explores how scholarly communications may evolve in the future with more open peer review systems and use of altmetrics and AI.
The Rise of Expert Voices: The Media and Health CareIvan Oransky
The document summarizes a presentation by Ivan Oransky on the rise of expert voices in media coverage of health and healthcare. It discusses who typically covers health news and their educational backgrounds. It then provides an overview of Reuters Health, how they choose and cover stories, and how other outlets cover stories. The presentation offers tips for experts to develop relationships with reporters, such as answering calls, sending newsworthy ideas, helping with press releases, using social media and blogs, and getting to know journalism organizations like the Association of Health Care Journalists.
This document discusses altmetrics, which are alternative metrics for measuring research impact beyond citations. It provides examples of altmetric data sources like tweets, blogs, and news articles. The document also presents case studies of researchers and articles to demonstrate altmetric measurements. It discusses issues around gaming the system and outlines future directions for altmetrics, including increased transparency, standards development, and assessing correlations with other impact measures.
There are several problems with the current system of publishing science. First, there is too much pressure on academics to publish in high impact journals and to publish many papers, especially for early career researchers. Second, the publication process takes too long and peer review can be inconsistent or lacking post-publication review. Third, there are too many open access journals of dubious quality, high costs for publication fees, and most papers are never widely read or cited.
This document discusses bibliometrics, which is the quantitative analysis of academic publications and their impact. It defines bibliometrics and explains that bibliometric measures are used to evaluate the impact and spread of research information. Common impact measures discussed include the journal impact factor, which measures the average number of citations to papers in a journal, and the H-index, which measures both the productivity and impact of a researcher's body of work. The document also outlines bibliometric services and databases that can be used to perform bibliometric analysis, such as Web of Knowledge, Journal Citation Reports, and Scopus.
The document discusses the key elements and requirements for complying with the NIH Public Access Policy, which requires investigators funded by NIH to submit final peer-reviewed manuscripts to PubMed Central upon acceptance for publication. The three main elements are: 1) retaining author rights to submit to PMC, 2) submitting the manuscript to PMC or NIH's manuscript submission system, and 3) providing proof of compliance on grant applications. The PI is ultimately responsible for approving manuscript submissions, though an author other than the PI may submit.
The document summarizes the NIH Public Access Policy, which requires researchers receiving NIH funding to submit final peer-reviewed manuscripts to PubMed Central within 12 months of official publication. It outlines the three steps for compliance: 1) managing copyright by checking agreements and modifying if needed, 2) submitting manuscripts to the NIH system if required, and 3) including the PMCID in future NIH proposals. Benefits of complying include increased exposure and citation of work. Publishers have varying levels of support for submitting manuscripts.
COVID-19 and Changing Paradigm in Scholarly communication Vasantha Raju N
The document discusses how the COVID-19 pandemic has impacted scholarly communications. It notes that researchers are publishing preprints to disseminate their research on COVID-19 quickly. This has led traditional publishers to speed up peer review and make more literature open access. It also discusses how preprint servers are benefiting research by allowing quick sharing of findings and how preprints differ from traditional publications. Finally, it explores how scholarly communications may evolve in the future with more open peer review systems and use of altmetrics and AI.
The Rise of Expert Voices: The Media and Health CareIvan Oransky
The document summarizes a presentation by Ivan Oransky on the rise of expert voices in media coverage of health and healthcare. It discusses who typically covers health news and their educational backgrounds. It then provides an overview of Reuters Health, how they choose and cover stories, and how other outlets cover stories. The presentation offers tips for experts to develop relationships with reporters, such as answering calls, sending newsworthy ideas, helping with press releases, using social media and blogs, and getting to know journalism organizations like the Association of Health Care Journalists.
This document discusses altmetrics, which are alternative metrics for measuring research impact beyond citations. It provides examples of altmetric data sources like tweets, blogs, and news articles. The document also presents case studies of researchers and articles to demonstrate altmetric measurements. It discusses issues around gaming the system and outlines future directions for altmetrics, including increased transparency, standards development, and assessing correlations with other impact measures.
There are several problems with the current system of publishing science. First, there is too much pressure on academics to publish in high impact journals and to publish many papers, especially for early career researchers. Second, the publication process takes too long and peer review can be inconsistent or lacking post-publication review. Third, there are too many open access journals of dubious quality, high costs for publication fees, and most papers are never widely read or cited.
Altmetrics provide alternative measures of impact beyond traditional citations by tracking attention on social media and other platforms. They can provide faster insights than citations, which take time to accumulate, and can measure impact on audiences beyond academics. However, altmetrics also have limitations as coverage varies by discipline and not all attention translates to citations or impact. Social media mentions have been shown to correlate with early citations and downloads, helping measure alternative concepts of impact.
HEALTH SERVICES ON THE NET - WHAT'S GOOD FOR ME? WHAT'S BAD? AND HOW DO I TEL...Tobias Neisecke
15th International Conference on WWW/INTERNET 2016
28 – 30 October, Mannheim, Germany
http://internet-conf.org/
HEALTH SERVICES ON THE NET - WHAT'S GOOD FOR ME? WHAT'S BAD? AND HOW DO I TELL THE
DIFFERENCE?
(Panel Session)
Thomas Wetter, Célia Boyer, Tobias Neisecke, Jonas Pendzialek and Monika Pobiruchin
When publishing research, one needs to be aware of all such actions that are unethical and hence, must be avoided. This presentation gives an overview of the topic.
Publication ethics: Definitions, Introduction and ImportanceVasantha Raju N
The document provides an overview of publication ethics and discusses its importance. It defines publication ethics as the principles and standards associated with publishing scientific research results. This includes giving proper credit and authorship, avoiding plagiarism and duplicate publication, managing conflicts of interest, and not falsifying or fabricating research data. The document highlights various unethical practices like plagiarism, gift authorship, and predatory journals. It also discusses guidelines from organizations like COPE, ICMJE and reporting standards to promote ethical research practices.
How to measure research impact on the webKinga Hosszu
This presentation explains how research impact measurement has changed with the advent of the internet, and provides examples of how impact can be measurement using several online tools.
This document summarizes a presentation about using Twitter effectively. It discusses Twitter basics like hashtags and tweet anatomy. It also provides advice for health professionals on Twitter like having an informative handle, only tweeting about professional issues, and making your own ground rules. The presenter discusses how they use Twitter to get research updates, learn about their profession, follow others in their field, promote their work, engage in conversations, and hear from patients. Overall recommendations are provided on how to "Twittertend" a conference by virtually following it and networking through Twitter.
Why Do We Need Twitter? For Health Professionals In Oncology, Hematology & Tr...Navneet Majhail
Presentation on how healthcare providers in oncology, hematology and blood/marrow transplantation can use Twitter for professional purposes. Presented at the 41st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), March 23, 2015, Istanbul, Turkey.
This document provides information for those considering graduate studies in statistics or biostatistics. It outlines the differences between biostatistics and statistics programs, recommended undergraduate coursework, the application timeline and process, and potential programs to consider. Biostatistics focuses on health-related problems while statistics takes a broader methodology approach. Coursework includes mathematical statistics, linear models, statistical computing and electives. Students also gain experience through teaching or research assistantships. The document recommends applying in December-January with letters of recommendation, a application letter, and resume. Popular programs are listed along with median salaries for BS, MS, and PhD degrees.
Social Media in Medicine - Minneapolis VA Grand RoundsPaul Sufka
This document summarizes a presentation on using social media in medicine given by Dr. Paul Sufka. The presentation covered Dr. Sufka's experience using social media as a rheumatologist, potential uses of social media for physicians including participating in online journal clubs and research dissemination, and tips for getting started on Twitter including following relevant experts and participating in online discussions.
Conference on Medicinal Chemistry & Computer Aided Drug DesigningOMICS International
This document provides information about the 2nd International Conference on Medicinal Chemistry & Computer Aided Drug Designing (MedChem & CADD-2013) to be held from October 15-17, 2013 in Las Vegas, Nevada. It discusses open access publishing and its benefits such as making research freely available online upon publication. Information is also provided about Medicinal Chemistry and Drug Designing: Open Access, two peer-reviewed open access journals on these topics launched by OMICS Group in 2011 and late 2011 respectively.
Innovations in Analytics for Academic Publishing and Research NetworkingTobias Abarbanell
How we use the frontiers and loop platforms to build reputation for academics: providing a variety of article level metrics with breakdown by demography, geography of readers, and by connecting social interaction with the articles of Academic Publishers.
Conference presentation from #DataSocial conference in SF, Apr-2015
Twitter for Journal Clubs and Medical EducationPaul Sufka
Twitter for Journal Clubs and Medical Education – Hennepin County Medical Center (HCMC) Grand Rounds 10/15/2015
Additional notes: http://paulsufka.com/hcmc
This document discusses ethics and integrity in data use and management. It begins by defining integrity and ethics. It then discusses key ethical principles like beneficence, respect for persons, and justice. It reviews guidelines and regulations around research ethics. It emphasizes the importance of data integrity and discusses challenges to integrity like human error and fabrication. It also discusses applications of ethics to areas like data collection, analysis, sharing and security. The overall message is that all individuals involved in research have a responsibility to uphold data integrity and ensure ethical data practices.
How Journalists Can Effectively -- And Safely -- Report on Scientific FraudIvan Oransky
Ivan Oransky discusses how journalists can effectively and safely report on scientific fraud. He recommends getting to know sites like PubPeer that allow commenting on published studies, reading the comments which may reveal issues, filing public records requests to obtain internal reports, checking sites for retractions and misconduct records, and collaborating with Retraction Watch. However, he cautions journalists to beware of potential legal issues and lawyers when investigating scientific fraud cases.
Journal of Gynecology Research (JGR) publishes original articles and research studies on, scientific advances, new medical and surgical techniques, obstetric management, and clinical evaluation of drugs and instruments and all aspects of gynecology including gynecological endoscopy, infertility, oncology contraception, urogynecology, fertility, and clinical practice and ultrasonography. It aims to publish the highest quality medical research in women's health, worldwide.
Tweeting about journal articles: Engagement, marketing or just gibberish?Nicolas Robinson-Garcia
This study analyzed tweets linking to dental journal articles to understand the role of Twitter in scholarly communication. The researchers found that the top tweeted papers were focused on by single-issue campaigners and social media managers, rather than broader discussion. Many Twitter accounts behaved like bots by repetitively tweeting full paper titles and URLs. While journals actively promoted their own content, tweets did not correlate well with citations and most showed little engagement with papers' contents. The researchers call for better understanding Twitter's role and distinguishing attention, marketing, and genuine engagement to inform altmetric studies and research evaluation.
Disseminating Scientific Research via Twitter: Research Evidence and Practica...Katja Reuter, PhD
About one-fifth of current scientific papers are being shared on Twitter. With nearly 69 million active U.S. Twitter users (24% of the U.S. adult population) and 328 million monthly active users worldwide, Twitter is one of the biggest social networks worldwide. Understandably, hopes are high that tweets mentioning scientific articles and research findings can reach peers and the general public. Studies show that most of the engagement with scientific papers on Twitter takes place among members of academia and thus reflects visibility within the scientific community rather than impact on society. However, there are ways to reach the broader public. This webinar will provide an overview of using Twitter to reach peers and non-specialist groups, the relationship between tweets and citations, and provide tips for building an academic Twitter presence.
Speaker: Katja Reuter, PhD, Assistant Professor of Clinical Preventive Medicine at the Institute for Health Promotion and Disease Prevention Research in the Department of Preventive Medicine at the Keck School of Medicine of USC; Director of Digital Innovation and Communication for the Southern California Clinical and Translational Research Institute (SC CTSI).
Learning objectives:
1. Describe the strengths and limitations of using Twitter for the dissemination of scientific research.
2. Describe practical approaches for building an academic presence on Twitter.
3. Describe approaches to identify and reach different audiences on Twitter.
Blogging, tweeting, sharing your work to reach policy makersTrish Groves
The document discusses using social media such as Twitter and blogs to disseminate research findings to policymakers. It provides examples of the Twitter and Facebook presence of academic journals. It also summarizes several studies that analyzed the relationship between social media activity like tweets and traditional citations and impact metrics. However, many researchers remain wary of using social media professionally due to concerns about compatibility with research, risks to careers, and unfamiliarity with the technologies. Guidelines from organizations like the GMC provide advice on using social media carefully and maintaining professional standards.
Altmetrics provide alternative measures of impact beyond traditional citations by tracking attention on social media and other platforms. They can provide faster insights than citations, which take time to accumulate, and can measure impact on audiences beyond academics. However, altmetrics also have limitations as coverage varies by discipline and not all attention translates to citations or impact. Social media mentions have been shown to correlate with early citations and downloads, helping measure alternative concepts of impact.
HEALTH SERVICES ON THE NET - WHAT'S GOOD FOR ME? WHAT'S BAD? AND HOW DO I TEL...Tobias Neisecke
15th International Conference on WWW/INTERNET 2016
28 – 30 October, Mannheim, Germany
http://internet-conf.org/
HEALTH SERVICES ON THE NET - WHAT'S GOOD FOR ME? WHAT'S BAD? AND HOW DO I TELL THE
DIFFERENCE?
(Panel Session)
Thomas Wetter, Célia Boyer, Tobias Neisecke, Jonas Pendzialek and Monika Pobiruchin
When publishing research, one needs to be aware of all such actions that are unethical and hence, must be avoided. This presentation gives an overview of the topic.
Publication ethics: Definitions, Introduction and ImportanceVasantha Raju N
The document provides an overview of publication ethics and discusses its importance. It defines publication ethics as the principles and standards associated with publishing scientific research results. This includes giving proper credit and authorship, avoiding plagiarism and duplicate publication, managing conflicts of interest, and not falsifying or fabricating research data. The document highlights various unethical practices like plagiarism, gift authorship, and predatory journals. It also discusses guidelines from organizations like COPE, ICMJE and reporting standards to promote ethical research practices.
How to measure research impact on the webKinga Hosszu
This presentation explains how research impact measurement has changed with the advent of the internet, and provides examples of how impact can be measurement using several online tools.
This document summarizes a presentation about using Twitter effectively. It discusses Twitter basics like hashtags and tweet anatomy. It also provides advice for health professionals on Twitter like having an informative handle, only tweeting about professional issues, and making your own ground rules. The presenter discusses how they use Twitter to get research updates, learn about their profession, follow others in their field, promote their work, engage in conversations, and hear from patients. Overall recommendations are provided on how to "Twittertend" a conference by virtually following it and networking through Twitter.
Why Do We Need Twitter? For Health Professionals In Oncology, Hematology & Tr...Navneet Majhail
Presentation on how healthcare providers in oncology, hematology and blood/marrow transplantation can use Twitter for professional purposes. Presented at the 41st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), March 23, 2015, Istanbul, Turkey.
This document provides information for those considering graduate studies in statistics or biostatistics. It outlines the differences between biostatistics and statistics programs, recommended undergraduate coursework, the application timeline and process, and potential programs to consider. Biostatistics focuses on health-related problems while statistics takes a broader methodology approach. Coursework includes mathematical statistics, linear models, statistical computing and electives. Students also gain experience through teaching or research assistantships. The document recommends applying in December-January with letters of recommendation, a application letter, and resume. Popular programs are listed along with median salaries for BS, MS, and PhD degrees.
Social Media in Medicine - Minneapolis VA Grand RoundsPaul Sufka
This document summarizes a presentation on using social media in medicine given by Dr. Paul Sufka. The presentation covered Dr. Sufka's experience using social media as a rheumatologist, potential uses of social media for physicians including participating in online journal clubs and research dissemination, and tips for getting started on Twitter including following relevant experts and participating in online discussions.
Conference on Medicinal Chemistry & Computer Aided Drug DesigningOMICS International
This document provides information about the 2nd International Conference on Medicinal Chemistry & Computer Aided Drug Designing (MedChem & CADD-2013) to be held from October 15-17, 2013 in Las Vegas, Nevada. It discusses open access publishing and its benefits such as making research freely available online upon publication. Information is also provided about Medicinal Chemistry and Drug Designing: Open Access, two peer-reviewed open access journals on these topics launched by OMICS Group in 2011 and late 2011 respectively.
Innovations in Analytics for Academic Publishing and Research NetworkingTobias Abarbanell
How we use the frontiers and loop platforms to build reputation for academics: providing a variety of article level metrics with breakdown by demography, geography of readers, and by connecting social interaction with the articles of Academic Publishers.
Conference presentation from #DataSocial conference in SF, Apr-2015
Twitter for Journal Clubs and Medical EducationPaul Sufka
Twitter for Journal Clubs and Medical Education – Hennepin County Medical Center (HCMC) Grand Rounds 10/15/2015
Additional notes: http://paulsufka.com/hcmc
This document discusses ethics and integrity in data use and management. It begins by defining integrity and ethics. It then discusses key ethical principles like beneficence, respect for persons, and justice. It reviews guidelines and regulations around research ethics. It emphasizes the importance of data integrity and discusses challenges to integrity like human error and fabrication. It also discusses applications of ethics to areas like data collection, analysis, sharing and security. The overall message is that all individuals involved in research have a responsibility to uphold data integrity and ensure ethical data practices.
How Journalists Can Effectively -- And Safely -- Report on Scientific FraudIvan Oransky
Ivan Oransky discusses how journalists can effectively and safely report on scientific fraud. He recommends getting to know sites like PubPeer that allow commenting on published studies, reading the comments which may reveal issues, filing public records requests to obtain internal reports, checking sites for retractions and misconduct records, and collaborating with Retraction Watch. However, he cautions journalists to beware of potential legal issues and lawyers when investigating scientific fraud cases.
Journal of Gynecology Research (JGR) publishes original articles and research studies on, scientific advances, new medical and surgical techniques, obstetric management, and clinical evaluation of drugs and instruments and all aspects of gynecology including gynecological endoscopy, infertility, oncology contraception, urogynecology, fertility, and clinical practice and ultrasonography. It aims to publish the highest quality medical research in women's health, worldwide.
Tweeting about journal articles: Engagement, marketing or just gibberish?Nicolas Robinson-Garcia
This study analyzed tweets linking to dental journal articles to understand the role of Twitter in scholarly communication. The researchers found that the top tweeted papers were focused on by single-issue campaigners and social media managers, rather than broader discussion. Many Twitter accounts behaved like bots by repetitively tweeting full paper titles and URLs. While journals actively promoted their own content, tweets did not correlate well with citations and most showed little engagement with papers' contents. The researchers call for better understanding Twitter's role and distinguishing attention, marketing, and genuine engagement to inform altmetric studies and research evaluation.
Disseminating Scientific Research via Twitter: Research Evidence and Practica...Katja Reuter, PhD
About one-fifth of current scientific papers are being shared on Twitter. With nearly 69 million active U.S. Twitter users (24% of the U.S. adult population) and 328 million monthly active users worldwide, Twitter is one of the biggest social networks worldwide. Understandably, hopes are high that tweets mentioning scientific articles and research findings can reach peers and the general public. Studies show that most of the engagement with scientific papers on Twitter takes place among members of academia and thus reflects visibility within the scientific community rather than impact on society. However, there are ways to reach the broader public. This webinar will provide an overview of using Twitter to reach peers and non-specialist groups, the relationship between tweets and citations, and provide tips for building an academic Twitter presence.
Speaker: Katja Reuter, PhD, Assistant Professor of Clinical Preventive Medicine at the Institute for Health Promotion and Disease Prevention Research in the Department of Preventive Medicine at the Keck School of Medicine of USC; Director of Digital Innovation and Communication for the Southern California Clinical and Translational Research Institute (SC CTSI).
Learning objectives:
1. Describe the strengths and limitations of using Twitter for the dissemination of scientific research.
2. Describe practical approaches for building an academic presence on Twitter.
3. Describe approaches to identify and reach different audiences on Twitter.
Blogging, tweeting, sharing your work to reach policy makersTrish Groves
The document discusses using social media such as Twitter and blogs to disseminate research findings to policymakers. It provides examples of the Twitter and Facebook presence of academic journals. It also summarizes several studies that analyzed the relationship between social media activity like tweets and traditional citations and impact metrics. However, many researchers remain wary of using social media professionally due to concerns about compatibility with research, risks to careers, and unfamiliarity with the technologies. Guidelines from organizations like the GMC provide advice on using social media carefully and maintaining professional standards.
The document summarizes research on the #ReSNetSLT Twitter community, which aims to connect speech and language therapists to improve patient care. It finds that over one year the community included 1652 tweets from 254 users, mainly discussing research, training, and the benefits of Twitter for networking and finding sources. A March 2018 discussion reflected the goals of connecting therapists globally. However, the impact on patient care is unknown. Building similar networks requires structuring discussions, being inclusive, and identifying champions to support capacity building.
How does social media fit into the ethical, legal and professional boundaries of oncology nursing? What are concerns and opportunities that an oncology nurse must be aware of when interacting with colleagues, patients and professional social media sites?
At the end of this activity, the learner will be able to:
State the ethical, legal and social justice elements of social media.
Describe how to integrate social media into the practice of oncology nursing.
Develop tools and skills to apply social media to the oncology nurses’ professional and personal daily activities.
Presented in February of 2014 to ONS Chapter meetings.
How You can use Twitter as a Tool for PhD Health Research - Phdassistance.comPhD Assistance
We explore the rapidly growing field of using social media especially Twitter as a source of data for Health and Medicine related Research.
The types of data available and their application, the limitations in Methodology and standard guidelines with future areas of research are highlighted.
No one can escape living in the virtual world today. The virtual world is brimming with Information and knowledge whose scope is much beyond one had imagined even till five years ago. In their attempts to find comprehensive databases, health workers and researchers are tapping the potential of these major interactive sites. These sites transcend geography and hold the potential in providing significant data related to population health, preferences, trends, and behaviour patterns. Predominant among these are Facebook, Instagram, and Twitter with Twitter being the most used for public health research
To Learn More:https://bit.ly/2Ck3Lgr
Contact Us:
UK NO: +44-1143520021
India No: +91-8754446690
Email: info@phdassistance.com
The following resource was developed by RESYST for a research uptake and digital communications workshop held in Bangkok, Thailand.
In this resource:
- What is social media?
- Uses for social media in research uptake
- Online global health movements
- RESYST on social media
- How to get the most from twitter
Find more: http://resyst.lshtm.ac.uk/resources/resource-bank-research-uptake
How to Disseminate Knowledge and Promote Your Career Using Social MediaMichael Gisondi
This lecture was presented to faculty members in graduate medical education at Albert Einstein Healthcare Network on November 2, 2022.
I describe the use of social media to promote the careers of academic physicians and researchers. I explain how to build platform, disseminate research, teach, and be a public health advocate online using social media.
Presentation at AMIA 2013 Washington DC, Nov 19th, Panel S50 Social Media and Me. I am focussing on the use of social media for research, in particular as tool for filtering the literature, twimpact factor, altmetrics...
#SoMe for Surgeons: Opportunity & Peril - 2018 - St. Agnes Grand Rounds - finalNiraj Gusani
This document discusses the opportunities and risks of physicians using social media professionally. It begins by defining social media and providing statistics on its growth and medical professionals' use of platforms like Twitter. The document then explores how physicians, medical institutions, and patients currently use social media for accessing new information, education, collaboration, and more. It also outlines some of the key risks around privacy, professionalism, and information credibility. Overall, the document advocates for physicians to leverage social media wisely while following guidelines to address risks and opportunities it provides for medical knowledge sharing and community building.
This document discusses the potential benefits of using Twitter as an educational tool for medical students. It outlines how Twitter can help students stay up-to-date on current medical news and events through aggregated article streams and conference hashtags. It also describes how medical students can use Twitter to ask and answer questions using hashtags, engage in discussions, and find networking opportunities. However, the document also notes some limitations of Twitter, such as potential unprofessional online behavior, and provides recommendations for safe and effective usage.
Use and Applications of Social Media in ResearchHarris Lygidakis
This is a presentation about the Use and Applications of Social Media in Medical Research.
A big thanks to the #hcsmanz community and all the Twitter and Social Media users that made this presentation possible by providing valuable material.
How to Use Digital and Social Media to Recruit Participants into Research Stu...Katja Reuter, PhD
Here are suggestions for evaluating the proposed social media recruitment approaches in Case Study 2:
Facebook media group for expectant mothers:
- Request permission from group administrators before posting ads
- Ensure ads are clearly labeled as recruitment for a research study
- Do not collect any personal user data without consent
Targeted banner ads based on online activity:
- This approach raises significant privacy concerns due to extensive data collection and profiling without consent
- A less invasive approach would be to use broad targeting (e.g. expectant mothers) without collecting personal data
- Consider an opt-in approach where users consent to seeing relevant research study ads
In both cases, fully disclose the study purpose and risks/benefits, and how
Presentation at the Philippine National Health Research Week preconference meeting: Rallying Communicators for Science, Technology, and Innovation in Health | Society of Health Research Communicators (SHARE). 22 August 2017, Hotel Jen, Manila.
This research article discusses how professional social media can help connect researchers in a more rapid way. It analyzes data on the percentage of health care professionals and hospitals using social media. Professional social media networks allow researchers to post profiles, publications, and interests to connect with others in their field from around the world. While some sites publish untrusted information, social media and databases like PubMed and LinkedIn provide a way to quickly find articles and meet other professionals and researchers.
Disseminating Scientific Papers via Twitter: Practical Insights and Research ...SC CTSI at USC and CHLA
About one-fifth of current scientific papers are being shared on Twitter. With 230 million active users and 24 percent of the U.S. online population using the microblogging platform, hopes are high that tweets mentioning scientific articles reflect some type of interest by the general public and might even be able to measure the societal impact of research. However, early studies show that most of the engagement with scientific papers on Twitter takes place among members of academia and thus reflects visibility within the scientific community rather than impact on society. At the same time, some tweets do not involve any human engagement but rather are generated automatically by Twitter bots.
This talk focuses on identifying audiences on Twitter and teaches participants how to collect, analyze, visualize, and interpret diffusion patterns of scientific articles on Twitter. The course provides an overview of Altmetrics research and present the challenges – including methods and first results – of classifying Twitter user groups, with a particular focus on identifying members of the general public and measuring societal impact. The course will provide hands-on exercises and instructions on how to analyze by whom, when, and how scientific papers are shared on Twitter.
Speaker: Stefanie Haustein, Ph.D., Assistant Professor, School of Information Studies, University of Ottawa
Engaging Patients in Research: Does algorithmically created content have a ro...Katja Reuter, PhD
This presentation is a follow-up on the previous version: Spreading Research and Engaging Disease Communities – One Automated Tweet at a Time. Here we share new data and argue that Algorithmic content creation can serve as a potent model for ongoing value generation to foster patient loyalty and research participant recruitment.
Similar to Marilyn mann slides for qcor 2018 final (20)
Comparative effectiveness randomized trial to improve stroke care delivery c...Marilyn Mann
A Vanderbilt University Medical Center study comparing the current way stroke care is delivered with a redesigned model that better integrates rehabilitation and skilled nursing facilities as well as lay health educators who make home visits. A pilot project suggests this new model can decrease hospital length of stay and readmissions, recurrence rates, and lower cost.
1) A patient with familial hypercholesterolemia (FH) on PCSK9 inhibitors described facing step therapy requirements and high copays to access the drug, with an initial $1000 copay and $400 monthly copay.
2) A study found that only 30.9% of patients prescribed PCSK9 inhibitors ever received the therapy due to prior authorization denials and high copays, with prescription abandonment rates over 75% for copays over $350.
3) Medicare Part D plans have annual out-of-pocket costs for PCSK9 inhibitors and statins of nearly $5000 on average.
This document summarizes the results of the HOPE-3 Trial, which evaluated the effects of blood pressure lowering and statin use on cognitive and functional outcomes in older adults. The trial found that while both interventions reduced cardiovascular events, they did not significantly prevent cognitive or functional decline over 5.6 years. However, there were trends toward benefit of blood pressure lowering in those with the highest baseline blood pressure and longer duration of treatment. Rosuvastatin also had no adverse effects on cognition. In conclusion, the interventions were generally not effective at preventing cognitive or functional decline, but some subgroups may benefit.
Pcsk9 loss of-function genetic variant is associated with pre-diabetes and di...Marilyn Mann
PCSK9 loss-of-function genetic variant is associated with pre-diabetes and diabetes. The study investigated the effect of PCSK9 loss-of-function variants on the incidence of pre-diabetes and diabetes in a cohort with familial hypercholesterolemia. It found that individuals carrying the PCSK9 loss-of-function variant had a lower risk of coronary events but a higher occurrence of pre-diabetes and diabetes. Further research is needed to understand the potential long-term metabolic effects of PCSK9-lowering therapies and risk of new-onset diabetes.
Alirocumab effect on new-onset or worsening diabetes, blood glucose, and HbA1c.Marilyn Mann
In 9 randomized clinical trials of alirocumab including 2482 patients, 3.4% of patients on alirocumab reported treatment-emergent diabetes or worsening of preexisting diabetes compared to 3.1% of patients on placebo. Laboratory tests found that at 52 weeks, patients on alirocumab on average saw a 0.16 mmol/L increase in fasting glucose levels and a 0.10% increase in hemoglobin A1c levels compared to placebo.
This document is a complaint filed by Health Diagnostic Laboratory, Inc. (HDL) against Robert Bradford Johnson and F. Calhoun Dent III seeking preliminary and permanent injunctive relief. HDL alleges that Johnson and Dent, as owners of BlueWave Healthcare Consultants, violated confidentiality, non-competition, and non-solicitation provisions of HDL's Shareholder Agreement by refusing to renegotiate potentially non-compliant provisions in their sales agreement and threatening to compete with HDL after HDL terminated the sales agreement. HDL seeks an injunction to prevent Johnson and Dent from using HDL's confidential information and damaging its business relationships and goodwill with healthcare providers.
This document discusses Alberto Gomez's experience receiving an LVAD (Left Ventricular Assist Device) to treat his advanced heart failure at MedStar Washington Hospital Center. It describes how Alberto had faith and hope even when diagnosed, and was determined to make his LVAD treatment work despite challenges. It highlights how LVADs have revolutionized heart failure treatment by providing an alternative to transplant. It also notes how Alberto now supports other heart failure patients by sharing his experience and offering prayer.
1) The IMPROVE-IT trial investigated whether adding ezetimibe to simvastatin therapy provides additional cardiovascular benefit compared to simvastatin monotherapy in 18,144 high-risk patients who recently had an acute coronary syndrome.
2) Patients receiving ezetimibe/simvastatin had a lower rate of major cardiovascular events (32.7% vs 34.7%) over a median follow-up of 6 years, demonstrating the additional clinical benefit of further lowering LDL-C with ezetimibe.
3) Ezetimibe/simvastatin also reduced the rate of the composite endpoint of cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke compared to
Ph rma principlesforresponsibleclinicaltrialdatasharingMarilyn Mann
The document outlines commitments by biopharmaceutical companies to responsibly share clinical trial data with qualified researchers and the public. The key commitments are:
1) Sharing patient-level data, study-level data, and protocols with qualified researchers upon request to facilitate legitimate research. Requests will be reviewed by a scientific board.
2) Making clinical study report synopses publicly available after drug approval to help patients and doctors understand trial results. Full reports may also be shared with researchers.
3) Informing trial patients about results in a factual summary developed with regulators.
Ezzahti sijbrands mulder roeters van lennep familial hypercholesterolemia new...Marilyn Mann
This document summarizes new treatment options for familial hypercholesterolemia (FH), a genetic disorder associated with high cholesterol and increased risk of heart disease. It describes recent clinical trial results of monoclonal antibodies against PCSK9 (REGN727 and AMG145) that lowered LDL cholesterol by up to 68% with minimal side effects. It also discusses mipomersen, an inhibitor of apolipoprotein B synthesis that lowered LDL by 21-47% but was associated with elevated liver enzymes in 6-15% of patients, raising safety concerns. The new drugs show promise for improving cholesterol levels in FH patients but require further study of their long-term safety and impact on heart disease outcomes.
The CHMP refused marketing authorization for the drug Kynamro intended for treatment of patients with familial hypercholesterolemia. Kynamro works by blocking production of apolipoprotein B to reduce LDL cholesterol levels, but two clinical trials showed a high rate of patients stopping treatment due to side effects. The CHMP also had concerns about potential long-term liver damage and an increased risk of cardiovascular events. Upon re-examination, the CHMP's concerns remained unresolved and the refusal was confirmed. Patients currently receiving Kynamro through clinical trials or compassionate use programs will be able to continue treatment.
Ema scientific conclusions and grounds for refusal of mipomersenMarilyn Mann
- Mipomersen treatment results in statistically significant reductions in LDL-C, but high withdrawal rates of 50-70% by 2 years due to intolerability limit its long-term benefits.
- Mipomersen causes liver enzyme elevations and hepatic steatosis in many patients, which may progress to steatohepatitis and fibrosis over years. It is difficult to identify patients at risk of long-term liver damage.
- The clinical trials were not prospectively designed or adjudicated to assess cardiovascular outcomes, so limited conclusions can be drawn about mipomersen's effects on cardiovascular risk. Uncertainties remain regarding its long-term benefits and risks.
Oxman et al a surrealistic mega analysis of redisorganization theoriesMarilyn Mann
This surrealistic review summarizes the lack of empirical evidence for organizational theories and repeated reorganizations in healthcare. The authors discovered that the most common reason for reorganizations is "no good reason" and that they perpetuate cycles of change. They identified indicators of successful reorganizations as activities that waste money, like large consulting fees for friends. The authors propose ethics committees to review future reorganization proposals to reduce uncontrolled experimentation on healthcare providers and users.
Glasziou taking healthcare interventions from trial to practiceMarilyn Mann
The document discusses improving the reporting of healthcare interventions in clinical trials to facilitate moving findings from trials into practice. It notes that currently many trial reports do not adequately describe interventions, making it difficult or impossible for clinicians to replicate them. The document proposes that trial protocols and publications should provide detailed descriptions of intervention contents, delivery personnel, locations, doses, schedules, and the degree of flexibility allowed. This would help reduce waste from unusable findings and better support evidence synthesis, clinical practice, and health policy decisions.
Ioannidis why science is not necessarily self correctingMarilyn Mann
This document summarizes a hypothetical scenario describing how science could deteriorate on the planet F345 in the year 3045268. In this scenario:
- Most research is conducted in "null fields" where there are few or no genuine effects to discover.
- The primary goal is making extravagant claims to obtain more funding, rather than replicating or questioning results.
- Critical thinking is discouraged, and the most advanced science occurs where free thought is restricted.
- Young scientists are taught to prioritize statistically significant results over replicating or questioning findings.
This document discusses designing comparative effectiveness research networks and agendas. It describes how networks can be defined as diverse pieces of data pertaining to related research questions. The geometry and structure of networks can provide insights into the relationships between different research questions and comparisons. Key aspects of network geometry include size, diversity, co-occurrence, and homophily. Prospectively designing networks can help maximize the informativeness of research by enhancing the network geometry and incorporating data continuously.
The Committee for Medicinal Products for Human Use (CHMP) adopted a negative opinion, recommending the refusal of the marketing authorisation for the medicinal product Kynamro, intended for the treatment of certain forms of familial hypercholesterolaemia. While Kynamro was effective at reducing LDL cholesterol levels, the CHMP was concerned about its safety profile. A high proportion of patients stopped taking Kynamro due to side effects and there were concerns about liver toxicity and an increased risk of cardiovascular events. Therefore, the CHMP determined that the risks of Kynamro did not outweigh its benefits and recommended refusing its marketing authorisation.
Involveconference2 121120053215-phpapp02Marilyn Mann
Iain Chalmers argues that a significant amount of medical research is wasted due to issues such as:
1) Low priority questions being addressed instead of what matters most to clinicians and patients.
2) Many studies being poorly designed and not learning from existing evidence.
3) Important results from studies often not being published or reported, leading to bias.
He advocates for greater public involvement in setting research agendas and priorities to better align research with patient and clinician needs and reduce waste estimated at over $85 billion per year. The James Lind Initiative seeks to address research waste and improve focus on shared uncertainties.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Nano-gold for Cancer Therapy chemistry investigatory projectSIVAVINAYAKPK
chemistry investigatory project
The development of nanogold-based cancer therapy could revolutionize oncology by providing a more targeted, less invasive treatment option. This project contributes to the growing body of research aimed at harnessing nanotechnology for medical applications, paving the way for future clinical trials and potential commercial applications.
Cancer remains one of the leading causes of death worldwide, prompting the need for innovative treatment methods. Nanotechnology offers promising new approaches, including the use of gold nanoparticles (nanogold) for targeted cancer therapy. Nanogold particles possess unique physical and chemical properties that make them suitable for drug delivery, imaging, and photothermal therapy.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
PGx Analysis in VarSeq: A User’s PerspectiveGolden Helix
Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.
The purpose of this webcast is to:
Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.
Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.
1. TWITTER FORTHE PUBLIC GOOD
OR
WHYYOU SHOULD BE ONTWITTER
QCOR 2018
April 7, 2018
Marilyn Mann, JD
@MarilynMann
mannm@comcast.net
2. Disclosures
• AmericanCollege of Cardiology: travel expenses
• American Board of Internal Medicine: travel expenses
• Yale Center for Outcomes Research and Evaluation:
consulting fee for serving on a stakeholder advisory
committee for developing a performance measure
under a contract with CMS
2
3. What isTwitter?
■ A social media platform that allows users to send messages
(“tweets”) containing up to 280 characters.
■ The vast majority of tweets are public and can be seen by
anyone.
■ Twitter is highly interactive, allowing other users to reply to,
like, repost (“retweet”), and comment on other users’ tweets.
■ Tweets can contain links, images and videos.
■ Users can tag other users and geo-tag their tweets.
■ The use of hashtags allows users to find tweets that are linked
to a common topic or event. An example is a conference
hashtag, such as #QCOR18.
■ Databases composed of tweets are available for analysis by
health researchers.
3
9. How medical journals onTwitter can
stimulate interest /excitement
Journals are experimenting with a variety of ways to generate interest and
excitement with theirTwitter feeds, including:
■ Editors tweeting from their personalTwitter accounts to comment on
articles
■ Attaching images
■ Visual abstracts
■ Podcasts (advertised onTwitter)
■ Quizzes and polls
■ Twitter journal clubs
■ Blog posts summarizing articles, cross-posted toTwitter
Fox, et al. JAHA. 2016;5:e003088. Ibrahim, et al. Annals of Surgery. 2017;266:e46-e48. Hawkins, et al. JACR.
2017;14:596-602.
9
12. Benefits ofTwitter involvement for health
professionals/researchers
■ Spreading information on an emerging innovation or best practice
■ Explaining and summarizing new research
■ Patient education and support
■ Better interaction with colleagues, forming new connections
■ Keeping up with the medical literature
■ Correcting/counteracting online misinformation
■ Engaging patients in clinical trials
■ Discussing important/controversial issues in health care
■ Promoting the public health
12
13. Case study: #RadialFirst discussion on
Twitter
My idea was to useTwitter to address the gap between the evidence and the practice around
radial approach.To effectively launch it, we needed lots of exposure, so I engaged several
radial experts around the country and they all agreed to joinTwitter. I came up with the
hashtag #RadialFirst and we all agreed to use it on every tweet related to radial approach.
We then decided on a launch date and time, and began tweeting all of the content we had on
our radial education slide decks…. After the first week, it took on a life of its own and it’s been
used by cardiologists, nurses/techs, and patients around the world.The adoption of
#RadialFirst was extremely rapid: between February 2017 and October 2017, #RadialFirst
had over 30.6 million impressions with over 2,500 unique tweeters.
SunilV. Rao
Walsh MN. Social Media and Cardiology. JACC 2018;71:1044-1047.
13
17. Health research usingTwitter: an
emerging field
■ A systematic review published in 2017 found 137 articles published between 2010 and
2015. Sinnenberg et al.Twitter as aTool for Health Research: A Systematic Review. Am
J Public Health. 2017;107:143, e1-e8.
■ Two general types of studies:
– Studies that analyze data fromTwitter (e.g., content analysis, surveillance of
volume of tweets about a particular topic, engagement ofTwitter users withTwitter
accounts or tweets)
– Studies that used theTwitter platform (e.g., to recruit participants for clinical trials
or to conduct an intervention onTwitter)
17
18. Publication date of articles in the
Sinnenberg systematic review
Sinnenberg, et al.Twitter as aTool for Health Research: A Systematic Review.Am J Public Health.
2017;107:143, e1-e8.
18
19. Summary
■ Twitter is a highly interactive social media platform that can be used for health
communication.
■ Health professionals, researchers and consumers/patients are usingTwitter for
networking, education, and public outreach.
■ Analysis ofTwitter data is a new field of health research.
■ TheTwitter platform can be used in connection with clinical trial recruitment, support
and communication and other health care interventions.
19